1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
Persson, Camilla U. LU ; von Stedingk, Kristoffer LU ; Fredlund, Elina LU ; Bexell, Daniel LU ; Påhlman, Sven LU ; Wigerup, Caroline LU and Mohlin, Sofie LU
(2020)
In Experimental Cell Research
Mark
- 2019
-
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
Mohlin, Sofie LU
;
Hansson, Karin
LU
;
Radke, Katarzyna
LU
;
Martinez, Sonia
;
Blanco-Apiricio, Carmen
;
Garcia-Ruiz, Cristian
LU
;
Welinder, Charlotte
LU
;
Esfandyari, Javanshir
LU
;
O'Neill, Michael
and
Pastor, Joaquin
, et al.
(2019)
In EMBO Molecular Medicine
11(8).
Mark
- Multidimensional intratumour heterogeneity in neuroblastoma
- 2018
- Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
- Promoter-associated proteins of EPAS1 identified by enChIP-MS – A putative role of HDX as a negative regulator
- Refined control of cell stemness allowed animal evolution in the oxic realm
- 2017
-
No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms
Mohlin, Sofie LU
;
Von Stedingk, Kristoffer
LU
;
Pietras, Alexander
LU
and
Påhlman, Sven
LU
(2017)
In Proceedings of the National Academy of Sciences of the United States of America
114(51).
p.10856-10858
Mark
-
Predominance of girls with cancer in families with multiple childhood cancer cases
Stjernfelt, Karl Johan LU ; von Stedingk, Kristoffer LU ; Wiebe, Thomas LU ; Hjorth, Lars LU ; Olsson, Håkan LU
and
Øra, Ingrid
LU
(2017)
In BMC Cancer
17(1).
Mark
- The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors
- Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum